Type 2 diabetes: Devices and technology

A tailored text messaging intervention might help lower glycated hemoglobin levels in people with type 2 diabetes in the short-term, but additional support may be needed for sustained improvements, US study data show.

The results of the phase 2 LIBERATES trial suggest that flash glucose monitoring could reduce the time people with type 2 diabetes spend in hypoglycemia in the period following an acute coronary syndrome.

Predictive low glucose alerts are associated with a reduced frequency and severity of rebound hyperglycemia among people using real-time continuous glucose monitoring, show study findings presented at the virtual ADA 80th Scientific Sessions.

Real-world data presented at the virtual ADA 80th Scientific Sessions highlight the benefits of the FreeStyle Libre continuous glucose monitoring system in reducing acute complications in people with type 1 or type 2 diabetes.

A rural telehealth program designed to fit with existing staff and equipment delivers large benefits for people with poorly controlled type 2 diabetes, researchers report.

Although helpful for primary care physicians, a type 2 diabetes treatment decision support tool may be missing the point for most people with poorly controlled glucose levels, suggest findings from a pilot study.

People with diabetes who access an online self-management portal through mobile devices have better medication adherence and glycemic control than those with computer-only or no access to the portal, researchers report.

Continuous subcutaneous insulin infusion of recombinant human regular U-500 insulin leads to greater glycated hemoglobin reductions at a much lower dose than multiple daily injections in people with type 2 diabetes, US research shows.

Giving people with type 2 diabetes “wear-and-forget” masked flash glucose monitoring to allow their healthcare providers access to detailed glucose profiles is feasible in primary care, but it is not clear how beneficial this is, show the results of the GP-OSMOTIC trial.

Glycated hemoglobin levels correlate strongly with continuous glucose monitoring-measured average blood glucose and hyperglycemia, but poorly with hypoglycemia, say researchers.

A statement from an ATTD consensus group has streamlined previously agreed continuous glucose monitoring metrics and set out time in range targets.

Delivery of bolus insulin via a patch results in similar glycemic control to that delivered by a conventional pen, with improvements in treatment satisfaction and quality of life, findings from a randomized trial suggest.

A large proportion of mobile apps for self-management of blood glucose do not provide real-time decision support for users with type 2 diabetes, researchers report.

Researchers show that closed-loop insulin delivery achieves markedly better glucose control than standard insulin management in hospitalized patients with hyperglycemia receiving enteral or parenteral nutrition.

Analyses of real-world audit data show positive initial results for the flash glucose monitoring system FreeStyle Libre and the sodium-glucose cotransporter 2 inhibitor canagliflozin.

The d-Nav system, which calculates insulin dose adjustments according to glucose levels, can help people with type 2 diabetes achieve larger reductions in glycated hemoglobin levels than with healthcare professional support alone, shows a randomized trial in The Lancet.

A low-cost, smartphone-based infrared (IR) camera works as well as a high-end version for the detection of diabetic foot ulcers (DFU), study findings indicate.

Insulin-dependent patients with type 2 diabetes using the d-Nav® system improve their glycemic control over and above that achieved with intensive healthcare professional support, research shows.

Fully closed-loop insulin delivery results in a markedly improved time in range among inpatients with type 2 diabetes receiving noncritical care, researchers have reported.

A diabetes self-management support system delivered by text message may help patients to improve their glycemic control, shows a study in The BMJ.